Core Viewpoint - Ying's Holdings has successfully passed its IPO application and plans to list on the Beijing Stock Exchange, but concerns about its future performance arise due to significant fluctuations in its financial results, heavy reliance on marketing over R&D, idle production capacity, and frequent quality control issues. Financial Performance - Ying's Holdings achieved revenues of 1.3 billion, 1.76 billion, and 1.97 billion from 2022 to 2024, with year-on-year growth rates of 37.4%, 35.7%, and 12.3% respectively. Net profits for the same period were 120 million, 220 million, and 210 million, with growth rates of 64.9%, 87.7%, and -4.4% respectively [3] - For 2025, the company expects revenues between 2.213 billion and 2.295 billion, representing a year-on-year growth of 12.11% to 16.26%, and net profits between 235 million and 246 million, with growth of 11.44% to 16.58% [3] R&D and Marketing Expenses - Ying's Holdings' R&D expenses from 2022 to 2025 were 5.53 million, 9.21 million, 17.15 million, and 8.05 million respectively, totaling 39.94 million over three and a half years, which is significantly lower compared to its marketing expenses [4][6] - The company's marketing expenses for the same period were 4.54 billion, 6.02 billion, 7.21 billion, and 3.97 billion, totaling 21.74 billion, which is approximately 54 times its R&D expenses [7] - The R&D expense ratio for Ying's Holdings was only 0.71% in the first half of 2025, significantly lower than its peers [8] Production Capacity and Utilization - The production capacity for Ying's Holdings' rice flour was 2,976 tons in 2022, with a utilization rate of 99.78%. However, by the first half of 2025, the utilization rate dropped to 70.04%, indicating that about 30% of its capacity is idle [10][11] - The company has also faced challenges with low utilization rates in its diaper production, with rates of 39.55%, 23.47%, and 16.79% from 2022 to 2024, and only 11.92% in the first half of 2025 [14] Quality Control Issues - Ying's Holdings has faced scrutiny over food safety, with two of its top five suppliers having been repeatedly flagged for food safety violations [15][17] - A third-party evaluation revealed discrepancies in the nutritional content of its products, raising concerns about the accuracy of its labeling [18][19] - Consumer complaints on social media platforms have highlighted issues with foreign objects found in its products, further damaging the company's reputation [20]

Core Viewpoint - Ying's Holdings Group Co., Ltd. is applying for an IPO on the Beijing Stock Exchange, focusing on infant nutrition and hygiene products, but faces challenges due to declining birth rates and recent product quality controversies [1][10]. Group 1: Company Overview - Ying's Holdings specializes in infant nutrition, particularly in scientific research on complementary foods, with core products including rice flour and hygiene products like diapers [1][10]. - The company has experienced rapid growth in 2022 and 2023, but forecasts a decline in growth for 2024, with a projected net profit decrease of 4.36% year-on-year [1][10]. Group 2: Market Challenges - The company acknowledges the risk of declining birth rates impacting the infant food and hygiene product market, which could adversely affect its business performance [1][10]. - Despite a projected net profit increase of 11.44% to 16.58% for the current year, the overall market environment remains challenging due to a continuous decrease in newborn numbers [1][10]. Group 3: Product Quality Controversy - In August, Ying's core product, infant rice flour, was reported to contain foreign objects, leading to widespread media coverage and scrutiny of its production methods [2][11]. - The company responded by asserting that all rice flour products are produced in-house and denied any outsourcing, emphasizing their commitment to quality and safety [6][15]. Group 4: Production Discrepancies - Despite the company's claims of in-house production, there are records in public disclosures indicating that a significant portion of raw materials is sourced from contracted manufacturers, raising questions about the accuracy of their statements [8][9][15][16]. - This discrepancy between public commitments and disclosed information may lead to consumer trust issues and complicate the company's IPO process [9][17].